Chongqing Lummy Pharmaceutical (300006) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Based on the latest financial reports, Chongqing Lummy Pharmaceutical (300006) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-14.90 Million ≈ $-2.18 Million USD) by net assets (CN¥1.85 Billion ≈ $271.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300006 company net worth for the company's overall valuation and market capitalisation.

Chongqing Lummy Pharmaceutical - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Chongqing Lummy Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chongqing Lummy Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chongqing Lummy Pharmaceutical ranked by their cash flow conversion efficiency. Explore Chongqing Lummy Pharmaceutical cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Hangzhou Advance Gearbox Group Co Ltd
SHG:601177
0.028x
Shanghai Xinhua Media Co Ltd
SHG:600825
-0.002x
Fujian Apex Software Co Ltd
SHG:603383
-0.023x
Chengdu B-ray Media Co Ltd
SHG:600880
-0.001x
Qiaoyin Environmental Tech Co Ltd
SHE:002973
0.015x
Power Mech Projects Limited
NSE:POWERMECH
0.087x
Si-Bone Inc
NASDAQ:SIBN
0.004x
BMC Medical Co. Ltd. A
SHE:301367
N/A

Annual Cash Flow Conversion Efficiency for Chongqing Lummy Pharmaceutical (2006–2024)

The table below shows the annual cash flow conversion efficiency of Chongqing Lummy Pharmaceutical from 2006 to 2024. View Chongqing Lummy Pharmaceutical (300006) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.88 Billion
≈ $275.59 Million
CN¥185.03 Million
≈ $27.08 Million
0.098x +155.72%
2023-12-31 CN¥2.12 Billion
≈ $310.54 Million
CN¥81.53 Million
≈ $11.93 Million
0.038x +46.92%
2022-12-31 CN¥2.18 Billion
≈ $319.73 Million
CN¥57.13 Million
≈ $8.36 Million
0.026x -46.58%
2021-12-31 CN¥2.21 Billion
≈ $323.70 Million
CN¥108.28 Million
≈ $15.84 Million
0.049x -73.15%
2020-12-31 CN¥1.23 Billion
≈ $180.22 Million
CN¥224.54 Million
≈ $32.86 Million
0.182x +30.35%
2019-12-31 CN¥1.65 Billion
≈ $241.99 Million
CN¥231.30 Million
≈ $33.85 Million
0.140x +6.75%
2018-12-31 CN¥1.72 Billion
≈ $252.28 Million
CN¥225.89 Million
≈ $33.05 Million
0.131x +267.72%
2017-12-31 CN¥1.72 Billion
≈ $252.11 Million
CN¥61.39 Million
≈ $8.98 Million
0.036x -52.53%
2016-12-31 CN¥1.67 Billion
≈ $245.00 Million
CN¥125.66 Million
≈ $18.39 Million
0.075x +599.18%
2015-12-31 CN¥1.69 Billion
≈ $247.28 Million
CN¥-25.41 Million
≈ $-3.72 Million
-0.015x +69.04%
2014-12-31 CN¥1.02 Billion
≈ $148.81 Million
CN¥-49.38 Million
≈ $-7.23 Million
-0.049x -173.18%
2013-12-31 CN¥1.13 Billion
≈ $164.73 Million
CN¥74.70 Million
≈ $10.93 Million
0.066x +159.29%
2012-12-31 CN¥710.51 Million
≈ $103.97 Million
CN¥18.18 Million
≈ $2.66 Million
0.026x +42.56%
2011-12-31 CN¥660.17 Million
≈ $96.60 Million
CN¥11.85 Million
≈ $1.73 Million
0.018x -73.23%
2010-12-31 CN¥561.59 Million
≈ $82.18 Million
CN¥37.66 Million
≈ $5.51 Million
0.067x -5.73%
2009-12-31 CN¥525.08 Million
≈ $76.84 Million
CN¥37.35 Million
≈ $5.47 Million
0.071x -43.18%
2008-12-31 CN¥137.79 Million
≈ $20.16 Million
CN¥17.25 Million
≈ $2.52 Million
0.125x -37.70%
2007-12-31 CN¥107.91 Million
≈ $15.79 Million
CN¥21.68 Million
≈ $3.17 Million
0.201x +66.59%
2006-12-31 CN¥64.39 Million
≈ $9.42 Million
CN¥7.77 Million
≈ $1.14 Million
0.121x --

About Chongqing Lummy Pharmaceutical

SHE:300006 China Drug Manufacturers - General
Market Cap
$811.19 Million
CN¥5.54 Billion CNY
Market Cap Rank
#9924 Global
#2596 in China
Share Price
CN¥5.25
Change (1 day)
+1.55%
52-Week Range
CN¥4.25 - CN¥6.58
All Time High
CN¥11.34
About

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. Chon… Read more